Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Conference attendance

1st Mar 2018 07:00

RNS Number : 3044G
Collagen Solutions PLC
01 March 2018
 

 

1 March 2018

Collagen Solutions to Present at Canaccord Genuity Musculoskeletal Conference &

Exhibit at American Academy of Orthopaedic Surgeons Conference

Dates: 6-9 March 2018

 

 

Collagen Solutions Plc (AIM: COS), (the "Company"), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine, including orthopaedic, dental, wound care, and cardiovascular applications, confirms two forthcoming conferences it will be attending in New Orleans, Louisiana, USA, between 6-9 March 2018.

· Jamal Rushdy, CEO, to present at the Canaccord Genuity Musculoskeletal Conference (6 March)· Company to Exhibit at the American Academy of Orthopaedic Surgeons "AAOS" Annual Conference (7-9 March)

 

AAOS is the world's largest and most prestigious annual orthopaedic meeting so attending this conference and presenting at the accompanying Canaccord Genuity Musculoskeletal Conference provides access to an extremely wide range of investors and manufacturers in areas of spine, trauma/extremities, foot and ankle, and sports medicine.

 

Commenting on the conferences, Jamal Rushdy, CEO said: "We are pleased to have the opportunity to present at the Canaccord Genuity Musculoskeletal Conference, where we will highlight our recently announced positive 8-year follow-on data from ChondroMimetic® demonstrating durable cartilage regeneration in keyhole knee surgery. We are also excited to be a first-time exhibitor at AAOS and to showcase our OEM capabilities and propriety device licensing opportunities to investors and industry partners. These meetings provide the opportunity to actively engage with orthopaedic companies on a global scale. We will also be providing hands-on demonstrations of prototypes for our Bone Graft Substitute, ChondroMimetic® Cartilage Repair Scaffold, and Fibrillar Collagen development programmes."

 

 

 

Collagen Solutions PlcJamal Rushdy, Chief Executive OfficerHilary Spence, Chief Financial OfficerLisa Baderoon, Head of Investor Relations

Tel: +44 (0) 141 648 9100Tel: +44 (0) 7721 413 496 or [email protected]

Cenkos Securities plc (NOMAD and Broker)Stephen KeysSteve Cox

Tel: +44 (0) 207 397 8900

Walbrook PRAnna DunphyHelen Cresswell

Tel: +44 (0) 20 7933 8780 or [email protected]: +44 (0) 7876 741 001

 

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic®. The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

The American Academy of Orthopedic Surgeons (AAOS)

AAOS is an orthopedic organisation. Founded at Northwestern University in 1933, as of 2015 AAOS had grown to include about 39,000 members. The group provides education and practice management services for orthopedic surgeons and allied health professionals. The AAOS also lobbies and works on public education. The AAOS describes itself as "the world's largest medical association of musculoskeletal specialists.

For more information go to: www.aaos.org

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZMGZZNRFGRZM

Related Shares:

COS.L
FTSE 100 Latest
Value8,275.66
Change0.00